Christian Brander obtained his PhD in Immunology from the University of Bern and completed his post-doctoral training at Harvard Medical School focusing on T cell immunity to HIV. He joined ICREA in 2008 with an appointment at the IrsiCaixa AIDS Research Institute. He is a co-inventor of the HIV "HTI" immunogen, which is developed clinically by Aelix Therapeutics Inc. where he is a co-founder and CSO. He serves as a curator of the Los Alamos HIV Database and is an Associate Professor at the University of Vic.
